GSK plc (GSK)

1,733.20
-20.60(-1.18%)
  • Volume:
    6,131,065
  • Bid/Ask:
    1,688.80/1,788.00
  • Day's Range:
    1,727.60 - 1,752.00

GSK Overview

Prev. Close
1,753.8
Day's Range
1,727.6-1,752
Revenue
36.48B
Open
1,749.4
52 wk Range
1,215.83-1,817
EPS
1.01
Volume
6,131,065
Market Cap
87.51B
Dividend (Yield)
75.00
(4.33%)
Average Volume (3m)
8,870,473
P/E Ratio
17.17
Beta
0.6
1-Year Change
29.34%
Shares Outstanding
5,061,174,547
Next Earnings Date
26 Jul 2022
What is your sentiment on GSK plc?
or
Market is currently closed. Voting is open during market hours.

GSK plc News

GSK plc Analysis

GSK plc Company Profile

GSK plc Company Profile

Employees
90096

GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellStrong SellNeutralStrong Buy
Technical IndicatorsStrong BuyStrong SellStrong SellStrong SellStrong Buy
SummaryBuyStrong SellStrong SellSellStrong Buy
  • I was able to earn over $37,000 weekly with an investment of $10,000. It been amazing trading and investing with Juliana reach her on 📞 📞 ✅✅✅✅🇺🇸👉👉❣️ whatap:+44 7380 395633
    0
    • Well it difficult to decide the right market this season, it will be more wise to invest and earn with automated protocol to manage high risks inflation and stay to 970% Rio, I'm currently on my fourth trade with my Expert Clara Austin and my portfolio has increased to $39,000, have seen the best way of making passive income despite the fail of crypto currency, investing with the right source is the best way to go. Write her on face📚book 👉CLARA AUSTIN via What🗳️App (+44 7360 508129)
      0
      • The detail above gave me €329k while using his signals
        0
        • This may go up further but I've started to take some profit as precaution. I suspect ulvr may not revise their offer after its sp tanking showing clear sentiments from shareholding to reject this move
          2
          • Moving closer to my 1800 tgt (posted on March 30). This stock pays very generous dividend I have to say
            3
            • ex-div in 13 days time. why risk selling now when you might not get back on the boat? pretty sure the company split will reach equivalent of 2000+ for the two new companies.
              1
              • 1587.80 looking at my previous comment "what do i know" near yearly HIGHS
                0
                • Breakout. Strong buy
                  0
                  • 1399.60p described as a good Divi stock but where's the potential capital growth... will wait for sub 1200.00p
                    2
                    • The current CEO seems to have lost confidence, time for a change to inject new life into the company
                      6
                      • the news from today remarked that investors present applauded during the event.
                        0
                      • the question is what percentage of GSK shareholders attended, most big investors gont go to such events
                        0
                      • while true, until we know who attended it's hard to gauge lost confidence. at the start of the day pre share holder day, the share price was 20p down, that swung to 40p up at one point, hardly signals negativity
                        0